About
Imhotex Limited is a virtual biopharmaceutical company founded in 2020 that develops a drug candidate to treat Crohn's Disease by leveraging specialist service providers for drug development.
Explore Imhotex Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.